Mankind Pharma Ltd (MANKIND) — Cash Flow Reinvestment Rate
Mankind Pharma Ltd (MANKIND) has a Cash Flow Reinvestment Rate of 0.17x as of September 2025, reinvesting Rs2.71 Billion (capex Rs2.71 Billion ) from operating cash flow of Rs16.37 Billion. See MANKIND FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Mankind Pharma Ltd Cash Flow Reinvestment Rate (2019–2026)
Historical reinvestment intensity for Mankind Pharma Ltd across 8 annual periods. For the full cash flow conversion analysis, see Mankind Pharma Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Mankind Pharma Ltd (2019–2026)
Year-by-year capital reinvestment analysis for Mankind Pharma Ltd. See Mankind Pharma Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.44x | Rs10.98 Billion | Rs25.16 Billion | Rs6.26 Billion | ▼ -22.3% |
| 2025 | 0.56x | Rs13.56 Billion | Rs24.13 Billion | Rs4.61 Billion | ▼ -43.2% |
| 2024 | 0.99x | Rs21.29 Billion | Rs21.52 Billion | Rs3.82 Billion | ▲ +76.2% |
| 2023 | 0.56x | Rs10.17 Billion | Rs18.13 Billion | Rs8.32 Billion | ▼ -86.1% |
| 2022 | 4.04x | Rs37.15 Billion | Rs9.20 Billion | Rs23.46 Billion | ▲ +199.3% |
| 2021 | 1.35x | Rs15.35 Billion | Rs11.37 Billion | Rs3.12 Billion | ▲ +116.4% |
| 2020 | 0.62x | Rs6.67 Billion | Rs10.70 Billion | Rs2.28 Billion | ▲ +25.8% |
| 2019 | 0.50x | Rs2.98 Billion | Rs6.00 Billion | Rs2.98 Billion | — |